What the Guidelines Tell Us About Cardiometabolic Syndrome

The Texas Heart Institute

S. Virani

What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Congenital Adrenal Hyperplasia

Kanakasabai Narasimhan

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Day 4 Recap: ACR Convergence 2024 Highlights

RheumNow

J. Pope, D. Liew, A. Sood

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

Ever-Evolving Lupus Case & Cytopenias in SLE

Cleveland Clinic Rheumatology

E. Littlejohn

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

Primary Aldosteronism and Implications for Primary Hypertension

Richard Auchus

Thrombotic Risks in Lupus: Can We Predict Risk of Thrombosis in SLE?…

RheumNow

M. Petri

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

Interview with IgA Nephropathy Patient Alistair

Leicester IgA Nephropathy

L. Iga Nephropathy